Sexually Transmitted Infections

1stxer tony38011 scorpio32 576 Users are discussing this topic

oPatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

The Venereal Diseases Act of 1917 defined three such diseases. They were syphilis, gonorrhoea and chancroid. In the UK, chancroid is unimportant and often forgotten although it is still troublesome in some parts of Africa. Syphilis ebbed but has been resurgent and the prevalence of gonorrhoea is often taken as an index of the degree of promiscuity in the community.

The generic term for venereal disease (VD) was changed to sexually transmitted diseases (STDs) and the VD clinics became special clinics as new euphemisms were devised to hide the embarrassment of society. More recently the speciality was called genitourinary medicine (GUM). The term sexually transmitted infections (STIs) is now used in preference to STDs because, strictly speaking, infections are not always associated with symptoms whereas diseases are. 

NEW - log your activity

  • Notes Add notes to any clinical page and create a reflective diary
  • Track Automatically track and log every page you have viewed
  • Print Print and export a summary to use in your appraisal
Click to find out more »

The number of diseases that are usually transmitted by sexual intercourse or which may be transmitted by that route, is much greater than the three defined by the Venereal Disease Act.[1] The following are classified as STIs:[2] 

Many of these diseases are covered in more detail under the specific appropriate article.

  • After a surge in STIs during the First World War there was a lull between wars and another surge during the Second World War. Some young men going off to war sought comfort in a way that put them at risk of acquiring STIs.
  • The 1960s saw an unprecedented availability of 'the pill' and increased promiscuity, without barrier contraception. The slogan of the young was 'make love, not war' and the use of drugs became more prevalent. There was an unrealistic expectation that antibiotics could cure all STIs.
  • The advent of AIDS was a chilling reminder of the limitation of antibiotics and, whilst promiscuity fell, as indicated by the incidence of gonorrhoea, this fall was only temporary.
  • Figures collected in 2008 showed that people in the16-24 age group accounted for around half of all newly diagnosed STIs in the UK.[17] 
  • Recent reports from Public Health England (PHE) - formerly the Health Protection Agency - give much cause for concern. Unsafe sexual practices amongst the young are reflected in higher rates of infection.[18] 
  • Of particular concern is the very high rate of chlamydia. Approximately 3-7% of sexually active women under the age of 24 and men aged between 20 and 24 may be currently infected.[2] 
  • Some of the increases in gonorrhoea and chlamydia diagnoses among young people may reflect increased attendance of young people at GUM clinics and, for chlamydia, increased and more sensitive testing.
  • Diagnoses, however, will underestimate the true level of infection in the UK, as many infections are asymptomatic.
  • Between 1997 and 2007, annual diagnoses of infectious syphilis increased twelvefold (from 301 to 3789).[2] 

Modes of transmission

To make a meaningful analysis of the facts and figures, it is important to look at the various ways by which the diseases may be spread. Not all such diseases are always spread by sexual activity. Transmission of infection can occur, for example, by intravenous drug abuse. Some diseases can be vertically transmitted from mother to child.

The pool of undiagnosed disease in a population is also an important problem. Such people can spread infection unwittingly. The number of people carrying undiagnosed infection varies according to the disease concerned. In many cases, infection remains undiagnosed as the individual is asymptomatic. The disease may be more likely to produce symptoms in one sex than the other but it remains contagious. For example, a man may readily see a primary chancre of syphilis on his glans whilst a woman is unaware of one on her cervix. Candida may cause vaginal discharge and pruritus vulvae but often in men it causes no symptoms.

Risk factors

The risk of acquiring STIs is greatest in those who are promiscuous, especially if they do not use barrier contraceptives. Other factors associated with a higher incidence of STIs are:[2][19][20]

  • Young age
  • Failure to use barrier contraceptives
  • Non-regular sexual relationships
  • Homosexuality
  • Intravenous drug use
  • African origin (sub-Saharan Africa)
  • Social deprivation
  • Prostitution
  • Poor access to advice and treatment of STIs

It is important to have some perspective on what constitutes 'normal' sexual activity. For example, since the 1990s there has been a trend to have first sexual intercourse earlier, an increase in the number of people having multiple partners and an increase in the number of men having sex with men.[21] 

Most STIs are best treated in a GUM clinic, as they have expertise in diagnosis and treatment as well as the ability to perform contact tracing. However, many patients with STIs present to GPs and it is essential that the initial advice and information should be correct even if definitive diagnosis and treatment are not given.

Sexual history

A sexual history is essential to guide decisions about management, or additional examinations or tests that might benefit the patient with suspected STI. It is essential that privacy be maintained. Details are covered in the separate article Sexual History Taking.

Taking a sexual history can present problems in general practice for many reasons. For example:

  • Patients are often reluctant to talk about their condition because of the stigma associated with STIs.
  • Patients may not appreciate that their symptoms are the result of an STI.
  • Inexperience or lack of knowledge amongst GPs.
  • Colluding with patients to 'play down' symptoms.
  • Lack of time to assess adequately.
  • The sensitivity of the subject for doctor and patient (particularly when the doctor has known the patient and family for many years).
  • Problems posed by the need for intimate examinations (use of chaperones, for example).

Examination

  • Avoid the possibility of others walking in on the examination.
  • It is usually advisable to have a chaperone when examining patients of the opposite sex.
  • It is appropriate to begin with a general assessment, including vital signs, inspection of the skin and detection of signs of systemic disease.
  • Remember basics before examining:
    • Ensure that the examination can be conducted in privacy.
    • Wash hands well (water and soap).
    • Use a sheet or clothing to cover the patient.
    • Position the patient and ensure they are comfortable.
    • Explain what you are about to do.
    • Put on a suitable examination glove.
    • Carry out the examination in good light.

Female patients:
There are three components to the female genital examination (assuming speculum/equipment are available):

  • External genital examination:
    • Inspect the perineum and anus - using the gloved hand.
    • Look for lumps, swelling, lymphadenopathy, abnormal discharge, sores, ulcers, tears and scars around the genitals and in between the skin folds of the vulva.
  • Speculum examination for:
    • Vaginal discharge and redness of the vaginal walls (vaginitis).
    • Ulcers, sores or blisters.
    • Cervical abnormalities (tumours, contact bleeding or discharge).
  • Bimanual examination:
    • Lower abdominal tenderness (when pressing with the outside hand).
    • Cervical motion tenderness (often evident from facial expression) when the cervix is moved from side to side with the fingers of the gloved hand in the vagina.
    • Uterine or adnexal tenderness when pressing the outside and inside hands together.
    • Any abnormal swelling (remember pregnancy, uterovaginal prolapse, ovarian cysts, tumours, etc).

Male patients:

  • Ask the patient to stand up and lower his underpants to his knees (or examine with the patient in a lying position if preferred).
  • Palpate the inguinal region for enlarged lymph nodes or buboes.
  • Palpate the scrotum, feeling for the testis, epididymis and spermatic cord on each side.
  • Examine the penis, noting any rashes or sores.
  • Ask the patient to pull back the foreskin if present and look at the glans penis and urethral meatus.
  • If there is no obvious discharge, ask the patient to milk the urethra.
  • Ask the patient to turn his back to you and bend over, spreading his buttocks slightly. This can also be done with the patient lying on his side with the top leg flexed up towards his chest.
  • Examine the anus for ulcers, warts, rashes, or discharge.

History and examination may lead to the detection of STI which may be entirely unsuspected by the patient.

The most reliable source of information is that published by the Medical Foundation for AIDS & Sexual Health (MedFASH).[22] 

More extensive testing is available by referral to a local GUM clinic. All pathology laboratories have their own operating policies. It is often important to discuss tests with the local laboratory. The processing of samples varies considerably and may depend on the clinical information provided. There are other guidelines produced from PHE and the Association of Medical Microbiologists to inform healthcare professionals working in laboratories.

Tests vary around the country, so you should be familiar locally with:

  • Which swabs to take
  • Where to swab
  • How to take a sample
  • Transport issues
  • The sensitivity and specificity of tests (as false positives and false negatives occur)

If there is a particular local need, consider:

  • Going on a Sexually Transmitted Infection Foundation (STIF) course[23]  
  • Talking to your local GUM clinic and microbiology laboratory

What to test for and when[2] 

HIV testing

Determine whether you practise in an area of high HIV prevalence (>2 per 1,000; the local GUM specialist can advise).

In areas of high prevalence HIV testing should be offered to:
  • All newly registered patients
  • All 'at-risk' patients:
    • Anyone with an STI
    • Men who have sex with men
    • Those buying/selling sex
    • Those from countries of high HIV prevalence
    • Intravenous drug users
    • Any sexual partner of the above
  • All those with 'clinical indicator diseases'

In areas of low prevalence HIV testing should be offered to:

  • 'At-risk' patients
  • All those with 'clinical indicator diseases

For more information about clinical indicator diseases see separate article Human Immunodeficiency Virus (HIV)

The HIV test

  • In-depth counselling is not necessary.
  • Emphasise the benefits of testing (earlier diagnosis leads to better prognosis, as effective treatment is now available).
  • Reassure patients that insurance companies do not enquire about negative results.
  • Send 10 mls of clotted blood to Virology, marked 'HIV test'.
  • Document how the patient will be informed of the results.
  • Re-test if within the three-month window period.
  • If negative, discuss risk reduction. If positive, refer according to local pathways - urgency to depend on the clinical status of the patient. 

Asymptomatic patients:

Those at high risk of STIs are:

  • Under the age of 25; and/or
  • With a new sexual partner within the previous 12 months.

Women:

  • Test for Chlamydia trachomatis.
  • In areas of high prevalence of gonorrhoea (or if there is a local outbreak) a test for Neisseria gonorrhoeae should be undertaken in high-risk patients.
  • Trichomonas (relatively uncommon and usually symptomatic but should be tested for).
  • It is not possible to exclude herpes genitalis by 'screening'. Only test for herpes if lesions are present.[10]
  • In asymptomatic patients there is no value in taking samples for bacterial vaginosis or candida[12] (neither of which is strictly sexually transmitted).

Men:
High-risk groups (above):

  • Urine test for chlamydia and gonorrhoea.
  • A positive test for gonorrhoea should prompt referral to a GUM clinic for a gonorrhoeal culture to be obtained (this confirms diagnosis and gives antibiotic sensitivities prior to treatment).

Symptomatic patients


Women:
  • Symptomatic women in high-risk groups (aged under 25 and with a new sexual partner within the previous 12 months): test for:
    • Gonorrhoea
    • Chlamydia
    • Bacterial vaginosis
    • Trichomonas
    • Candida[12]
  • Symptomatic women aged over 25 years:
    • A risk assessment should be undertaken.
    • Test for chlamydia and gonorrhoea whatever the genital symptoms (if not previously performed).
    • The most common cause of vaginal discharge will be either bacterial vaginosis or candida.
    • If there has been no change in sexual partner since the last test for chlamydia/gonorrhoea, then empirical treatment based on the pH paper result, with further investigation if the symptoms do not resolve, should suffice. For normal vaginal pH, treat as if candida; for elevated pH (5.0), treat for bacterial vaginosis.
    • If there are urinary symptoms and/or lower abdominal pain, sexually transmitted organisms should be excluded in the high-risk group and considered on the basis of a risk assessment in those over the age of 25 with no change of partner.
Men:
  • Urethral discharge and/or dysuria usually indicate an STI.[8]
  • Ideally, a diagnosis of urethritis needs to be made for which microscopy of a Gram-stained slide is required (see separate article Gonorrhoea).
  • Tests for gonorrhoea and chlamydia are recommended.
  • Men with testicular swelling or discomfort should have STI excluded.[16] The most common cause of these symptoms in men aged under 40 is C. trachomatis. A midstream specimen of urine (MSU) is also advisable to exclude a urinary tract organism as a cause of this, especially in those aged over 40.
  • Details can be found in the articles linked above under the heading 'Diseases which may be transmitted sexually'.
  • Management of STIs in children and young people is beyond the scope of this article.[24]  
  • Anyone who is being treated for an STI should abstain from sexual activity until treatment (their own and their partner's) is complete.
  • Partner notification is difficult to undertake comprehensively in primary care and is best left to specialist GUM services.[2] 
  • Single-dose antibiotics are often used, where possible, to improve compliance.

The Health Protection Agency report for 2008 suggested:[25]

  • Better access for young people to sexual health services which can deliver advice, screening and treatment of STIs.
  • Interventions to promote sexual health, which are of proven effectiveness, are needed.
  • Health education to provide information and skills is needed in the area of relationships and sexual health.
  • Information to enable primary care to target preventative measures is needed.

The social stigma of having an STI is enormous and the GUM clinics, since their origin, have been discreet and kept anonymity for their patients. Patients are often given a number so that they do not have to present with a name. They tend to have a discreet entrance in a distant part of the hospital and, to ensure compliance, the drugs they dispense are exempt from prescription charges. It is the only part of the NHS that will not routinely inform the patient's GP of attendance.

Despite anonymity and sensitivity of diagnosis, clinics will attempt to trace contacts of those with STIs. This is a very important role. A recent development, however, has been the Golding prosecution. This involved the prosecution of David Golding who was jailed for 14 months after failing to inform a partner - who subsequently became infected - that he had genital herpes. There is concern amongst public health experts that this will inhibit patients with concerns from seeking help.[2] 

Traditional methods of risk reduction need to be reviewed to ensure that they are fit for purpose in modern society. Family interventions and peer-led interventions (eg, lay advisers in schools) have been shown to be at least as effective as interventions by health professionals.[26][27] 

Further reading & references

  • Shepherd J, Kavanagh J, Picot J, et al; The effectiveness and cost-effectiveness of behavioural interventions for the prevention of sexually transmitted infections in young people aged 13-19: a systematic review and economic evaluation. Health Technol Assess. 2010 Feb;14(7):1-206, iii-iv. doi: 10.3310/hta14070.
  • World Helth Organization; Global strategy for the prevention and control of sexually transmitted infections: 2006 - 2015. Breaking the chain of transmission,2007.
  • National guideline for the management of chancroid, British Association of Sexual Health and HIV (2014)
  1. Plumb D; Sexual Transmitted Diseases, A Historical Perspective.
  2. Sexually Transmitted Infections in Primary Care; Royal College of General Practitioners and British Association for Sexual Health and HIV (Apr 2013)
  3. Management of syphilis; British Association for Sexual Health and HIV (2008)
  4. Management of gonorrhoea; British Association for Sexual Health and HIV (2011)
  5. Management of chancroid, British Association for Sexual Health & HIV (2007)
  6. UK Guidelines for the management of sexual and reproductive health of people living with HIV infection, British Association for Sexual Health and HIV (2008)
  7. Management of chlamydia trachomatis genital tract infection, British Association for Sexual Health and HIV (2006)
  8. Management of non-gonococcal urethritis, British Association for Sexual Health and HIV (2007 updated December 2008)
  9. Management of lymphogranuloma venereum, British Association for Sexual Health and HIV (2006)
  10. Management of genital herpes; British Association for Sexual Health and HIV (2007)
  11. Management of anogenital warts, British Association for Sexual Health and HIV (2007)
  12. Management of vulvovaginal candidiasis; British Association for Sexual Health and HIV (2007)
  13. Management of Pelvic Inflammatory Disease; British Association for Sexual Health and HIV (2011)
  14. Management of pediculosis pubis; British Association for Sexual Health and HIV (2007)
  15. Management of trichomonas vaginalis, British Association for Sexual Health and HIV (2007)
  16. Management of epididymo-orchitis; British Association for Sexual Health and HIV (2010 updated June 2011)
  17. Young people carry disproportionate burden of sexually transmitted infections in UK; Public Health England, 2008
  18. Sexually Transmitted Infections; Public Health England, 2013
  19. Manhart LE, Aral SO, Holmes KK, et al; Influence of study population on the identification of risk factors for sexually transmitted diseases using a case-control design: the example of gonorrhea. Am J Epidemiol. 2004 Aug 15;160(4):393-402.
  20. Gaspari V, D'Antuono A, Bellavista S, et al; Prostitution, sexual behavior and STDs. G Ital Dermatol Venereol. 2012 Aug;147(4):349-55.
  21. One to one interventions to reduce the transmission of sexually transmitted infections (STIs) and to reduce the rate of under 18 conceptions especially among vulnerable and at risk groups; NICE Public Health Guidance (February 2007)
  22. HIV in Primary Care; Medical Foundation for AIDS & Sexual Health (2011)
  23. Sexually Transmitted Infection Foundation (STIF) Course; British Association for Sexual Health and HIV
  24. Management of sexually transmitted infections and related conditions in children and young people; British Association for Sexual Health and HIV (2010)
  25. HIV and STIs; Public Health England
  26. Kao TS, Gibbs MB, Clemen-Stone S, et al; A comparison of family interventions to address adolescent risky behaviors: a literature review. West J Nurs Res. 2013 May;35(5):611-37. doi: 10.1177/0193945912465021. Epub 2012 Nov 18.
  27. Lazarus JV, Sihvonen-Riemenschneider H, Laukamm-Josten U, et al; Systematic review of interventions to prevent the spread of sexually transmitted infections, including HIV, among young people in Europe. Croat Med J. 2010 Feb;51(1):74-84.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Richard Draper
Current Version:
Peer Reviewer:
Dr Helen Huins
Document ID:
2773 (v29)
Last Checked:
07/06/2013
Next Review:
06/06/2018